NCT06912087 2025-12-02Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCCUniversity of ChicagoPhase 1 Recruiting36 enrolled
NCT02128906 2025-03-26Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction DesignUniversity of PittsburghPhase 2 Recruiting120 enrolled